We hypothesize that this interaction could possibly lead to conformational changes in PDH that subsequently could modulate its accessibility to PDH kinase or PDH phosphatase, and thus, alter its enzymatic activity, by keeping it to its phosphorylated inactive state, in favor of tumor progression [31]. This evidence concerns the gene PDP1 and neoplasm.